Auckland, New Zealand

Gillian Clark, Legal Representative


Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Auckland, NZ (2012)
  • North Shore, NZ (2012)

Company Filing History:


Years Active: 2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gillian Clark - Innovator in Endocrine Disorder Treatments

Introduction

Gillian Clark is a prominent legal representative and inventor based in Auckland, New Zealand. She has made significant contributions to the field of medicine, particularly in the treatment of endocrine disorders. With two patents to her name, her work focuses on improving the health and metabolism of patients suffering from insulin-like growth factor-1 deficiency.

Latest Patents

Gillian's latest patents include "Methods for treatment of insulin-like growth factor-1 deficiency" and "Method and device for diagnosing and treating insulin-like growth factor deficiency disorders." The first patent provides methods and compositions for increasing growth rates and alleviating symptoms in patients with partial endogenous growth hormone activity. It details a method of administering insulin-like growth factor-1 (IGF-1) to improve metabolism, emphasizing the importance of daily administration. The second patent introduces standard deviation score (SDS) calculators for transforming IGF-1 concentrations into standard deviation scores, which are crucial for assessing IGF-1 production rates in response to growth hormone therapy.

Career Highlights

Gillian has established herself as a key figure in her field, leveraging her legal expertise to navigate the complexities of patent law and innovation. Her work at Tercica, Inc. has allowed her to collaborate with other professionals in the industry, further enhancing her contributions to medical science.

Collaborations

Some of her notable coworkers include Ross Graham Clark and George M Bright. Their collective efforts have contributed to advancements in the understanding and treatment of endocrine disorders.

Conclusion

Gillian Clark's innovative work in the treatment of insulin-like growth factor-1 deficiency showcases her dedication to improving patient outcomes. Her patents reflect her commitment to advancing medical science and her role as a leader in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…